Teachers Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Teachers Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,139	Closed	-$201K	–	3104
2018 Q1	$201K	Hold	23,139	–	–	﹤0.01%	2879
2017 Q4	$290K	Buy	23,139 +3,016	+15%	+$34.6K	﹤0.01%	2815
2017 Q3	$168K	Hold	20,123	–	–	﹤0.01%	2996
2017 Q2	$341K	Buy	+20,123	New	+$400K	﹤0.01%	2792
2016 Q2	–	Sell	-4,796	Closed	-$45K	–	3176
2016 Q1	$45K	Hold	4,796	–	–	﹤0.01%	3009
2015 Q4	$48K	Buy	+4,796	New	+$63.5K	﹤0.01%	3066

Other funds holding ZYNE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FTIOP

Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Teachers Advisors's ZYNE Position: Q2 2018 in Review

Teachers Advisors sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2018, closing a stake of 23,139 shares — an estimated $201K sold.

Teachers Advisors first reported a position in ZYNE in Q4 2015 and held it in 6 quarters. The position peaked at $341K in Q2 2017. 59 funds tracked by Wall St. Rank hold ZYNE as of Q2 2018.

Teachers Advisors reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2018 after selling out during the quarter.
Teachers Advisors sold 23,139 Zynerba Pharmaceuticals, Inc shares in Q2 2018, an estimated $201K.
Teachers Advisors first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2015 and held it in 6 quarters.
Teachers Advisors's Zynerba Pharmaceuticals, Inc position peaked at $341K in Q2 2017.
59 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.